Implementation and outcomes of monoclonal antibody infusion for COVID-19 in an inner-city safety net hospital: A South-Bronx experience
Authors:
- Sridhar ChilimuriSCSridhar Chilimuri
- Nikhitha MantriNMNikhitha Mantri
- Hitesh GurjarHGHitesh Gurjar
- Haozhe SunHSHaozhe Sun
- Sudharsan GongatiSGSudharsan Gongati
- Maleeha ZahidMZMaleeha Zahid
- Angel De La CruzACAngel De La Cruz
- Paavana VaranasiPVPaavana Varanasi
- Dongmin ShinDSDongmin Shin
- Suresh Kumar NayuduSNSuresh Kumar Nayudu
Open Access
- 11 September 2021
- journal article
- research article
- Published by Elsevier in Journal of the National Medical Association
- Vol. 113 (6) , 701-705
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2Communications Biology, 2021
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19JAMA, 2021
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19New England Journal of Medicine, 2021
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19New England Journal of Medicine, 2021
- Neutralizing Antibody LY-CoV555 for Outpatient Covid-19New England Journal of Medicine, 2021
- Mild or Moderate Covid-19New England Journal of Medicine, 2020